Long-acting β-agonists, tachyphylaxis, and corticosteroids

Chest

Volumn 109, Issue 4, 1996, Pages 862-864

  Sears, M R ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FENOTEROL; HISTAMINE; ISOPRENALINE; LONG ACTING DRUG; METHACHOLINE; SALBUTAMOL; SALMETEROL;

ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; DRUG MEGADOSE; DRUG TOLERANCE; EDITORIAL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MORTALITY; PRIORITY JOURNAL; PROVOCATION TEST; TACHYPHYLAXIS;

EID: 0029958776     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.4.862     Document Type: Editorial

References (32)

1. Chung KF The current debate concerning ß-agonists in asthma: a review J R Soc Med 86 1993 96 100
2. Reisman RE Asthma induced by adrenergic aerosols J Allergy 46 1970 162 177
3. Van-Metre TE Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticus J Allergy 43 1969 101 113
4. Speizer FE Doll R Heaf P Observations on recent increase in mortality from asthma BMJ 1 1968 335 339
5. Sears MR Taylor DR The ß2-agonist controversy: observations, explanations and relationship to asthma epidemiology Drug Saf 11 1994 259 283
6. Sears MR Taylor DR Print CG Regular inhaled beta-agonist treatment in bronchial asthma Lancet 336 1990 1391 1396
7. Taylor DR Sears MR Herbison GP Regular inhaled ß-agonist in asthma: effect on exacerbations and lung function Thorax 48 1993 134 138
8. Cockcroft DW McPaarland CP Britto SA Regular inhaled salbutamol and airway responsiveness to allergen Lancet 342 1993 833 837
9. Cockcroft DW O'Byrne PM Swystun VA Regular use of inhaled albuterol and the allergen-induced late asthmatic response J Allergy Clin Immunol 96 1995 44 49
10. Inman MD O'Byrne PM The effect of regular inhaled albertol on exercise-induced bronchoconstriction Am J Respir Crit Care Med 153 1996 65 69
11. Britton MG Earnshaw JS Palmer JBD A twelve-month comparison of salmeterol with salbutamol in asthmatic patients Eur Respir J 5 1992 1062 1067
12. Kesten S Chapman KR Broder I A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma Am Rev Respir Dis 144 1991 622 625
13. Ramsdale EH Otis J Kline PA Prolonged protection against methacholine-induced bronchoconstriction by the inhaled ß2-agonist formoterol Am Rev Respir Dis 143 1991 901 998
14. Kemp JP Dockhorn RJ Busse WW Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm Am J Respir Crit Care Med 150 1994 1612 1615
15. Cartier A Ghezzo H L'Archeveque J Duration and magnitude of action of 50 and 100 pg of inhaled salmeterol in protecting against bronchoconstriction induced by hyperventilation of dry cold air in subjects with asthma J Allergy Clin Immunol 92 1993 488 492
16. Arvidsson P Larsson S Lofdahl C-G Formoterol, a new long-acting bronchodilator for inhalation Eur Respir J 2 1989 325 330
17. Ullman A Hedner J Svedmyr N Inhaled salmeterol and salbutamol in asthmatic patients: an evaluation of asthma symptoms and the possible development of tachyphylaxis Am Rev Respir Dis 142 1990 571 575
18. Newnham DM McDevitt DG Lipworth BJ Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma Am J Med 97 1994 29 37
19. Newnham DM Grove A McDevitt DG Subsensitivity of bronchodilator and systemic ß2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients Thorax 50 1995 497 504
20. Maesen FPV Nakratzas G Bantje TA Formoterol suspension aerosol: comparison with formoterol solution aerosol for 12 weeks in asthmatic patients Chest 102 1992 1544 1549
21. Cheung D Timmers MC Zwinderman AH Long-term effects of a long-acting ß2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma N Engl J Med 327 1992 1198 1203
22. Bhagat R Kalra S Swystun VA Rapid onset of tolerance to the bronchoprotective effect of salmeterol Chest 108 1995 1235 1239
23. Ramage L Lipworth BJ Ingram CG Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol Respir Med 88 1994 363 368
24. Holgate ST Baldwin CJ Tattersfield AE ß-adrenergic agonist resistance in normal human airways Lancet ii 1977 375 377
25. Svedmyr N Action of corticosteroids on beta-adrenergic receptors: clinical aspects Am Rev Respir Dis 14L 1990 S31 S38
26. Adcock IM Peters MJ Crown CR Interactions between steroids and ß-agonists in vitro Eur Respir J 7 1994 421s
27. Cockcroft DW Swystun VA Bhagat R Interaction of inhaled ß2-agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine Am J Respir Crit Care Med 152 1995 1485 1489
28. Yates DH Sussman H Shaw M Regular formoterol treatment in mild asthma: effect on bronchial responsiveness during and after treatment Am J Respir Crit Care Med 152 1995 1170 1174
29. Clark CE Ferguson AD Siddorn JA Respiratory arrests in young asthmatics on salmeterol Respir Med 87 1993 277 278
30. Bone RC Another word of caution regarding a new long-acting bronchodilator JAMA 273 1995 967 968
31. Castle W Fuller R Hall J Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment BMJ 306 1993 1034 1037
32. Pearlman DS Chervinsky P LaForce C A comparison of salmeterol with albuterol in the treatment of mild to moderate asthma N Engl J Med 327 1992 1420 1425